Hjem › Type 1-diabetes › Florida › Jacksonville
Type 1-diabetes kliniske forsøg i Jacksonville, FL
5 studier for Type 1-diabetes søger deltagere på steder i og omkring Jacksonville (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
RekruttererFase 3
- Nemours Children's Speciality Care- Jacksonville- Site Number : 8400040, Jacksonville
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
RekruttererFase 1/2
- Nemours Children's Health, Jacksonville
Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
Rekrutterer
- Nemours Children's Health, Jacksonville
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
RekruttererObservationsstudie
- Nemours Children's Health, Jacksonville
Registry for Stage 2 Type 1 Diabetes
RekruttererObservationsstudie
- Nemours Children's Speciality Care- Jacksonville- Site Number : 8400006, Jacksonville
Type 1-diabetes forsøg i andre byer
- Aurora, CO23 studier
- Boston, MA21 studier
- Seattle, WA18 studier
- Chicago, IL16 studier
- New Haven, CT15 studier
- New York City, NY15 studier
- Indianapolis, IN14 studier
- San Francisco, CA14 studier
- Miami, FL13 studier
- Gainesville, FL12 studier
- Philadelphia, PA11 studier
- Atlanta, GA11 studier
Andre studier i Jacksonville
- Brystkræft40 studier
- Ikke-småcellet lungecancer39 studier
- Kræft (alle typer)29 studier
- Metastatisk cancer28 studier
- Colorektal kræft27 studier
- Prostatakræft26 studier
- Overvægt25 studier
- Hjertesvigt21 studier
- Bugspytkirtelkræft20 studier
- Overvægt19 studier
- Multipelt myelom18 studier
- Lungecancer17 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.